SWISS RE AG |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| - CHF | -.--% |
|
+2.11% | +5.63% |
| 01:35pm | SWISS REINSURANCE COMPANY : Berenberg gives a Buy rating | ZD |
| 01:20pm | SWISS REINSURANCE COMPANY : Deutsche Bank reiterates its Neutral rating | ZD |
| Sales 2024 * | 49.47B 44.97B 3,908B | Sales 2025 * | 49.77B 45.24B 3,932B | Capitalization | 34.55B 31.41B 2,730B |
|---|---|---|---|---|---|
| Net income 2024 * | 3.86B 3.51B 305B | Net income 2025 * | 4.09B 3.72B 323B | EV / Sales 2024 * | 0.79 x |
| Net Debt 2024 * | 4.6B 4.18B 363B | Net Debt 2025 * | 4.61B 4.19B 364B | EV / Sales 2025 * | 0.79 x |
| P/E ratio 2024 * |
9.05
x | P/E ratio 2025 * |
8.51
x | Employees | - |
| Yield 2024 * |
6.05% | Yield 2025 * |
6.51% | Free-Float | 91.32% |
More Fundamentals
* Assessed data
More news
Latest transcript on Swiss Re AG
More recommendations
More press releases
More news
| Managers | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 55 | 30/06/16 | |
John Dacey
DFI | Director of Finance/CFO | 64 | 30/09/12 |
Velina Peneva
CIO | Chief Investment Officer | - | 31/12/16 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Larry Zimpleman
BRD | Director/Board Member | 72 | 19/04/18 |
| Director/Board Member | 68 | 20/04/17 | |
| Chairman | 63 | 20/04/17 |
Swiss Re Ltd is one of the world's leading reinsurance groups. Earned premiums break down by activity as follows:
- non-life reinsurance (51.6%): primarily damage, civil liability, automobile, accident, credit and guarantee, and other types of reinsurance;
- life and health reinsurance (34.7%; No. 1 worldwide): primarily life (69.2% of earned premiums) and health (30.8%);
- financial services (12.6%): asset management, investment capital, financial consulting, sales of structured products, etc.;
- others (1.1%).
Sector
Reinsurance
Calendar
21/08/2024
- Q2 2024 Earnings Call
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
HOLD
Number of Analysts
16
Last Close Price
119
USD
Average target price
124.1
USD
Spread / Average Target
+4.29%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +11.33% | 7.09B | |
| +10.73% | 6.5B | |
| +12.55% | 6.28B | |
| +4.95% | 4.53B | |
| +10.91% | 867M | |
| +23.86% | 711M | |
| +10.71% | 522M | |
| +112.30% | 433M | |
| +7.11% | 157M |
- Stock Market
- Equities
- SREN Stock
- SRENE Stock
